$BCRX what do we think will the pricing be on pill form for Gali? We know remdesivir is $400 per vial. I assume they'll have to team up with another company for manufacturing capacity. I'd think around 50 million pills to start, $100/pill would be $5B. Feels like the easiest route is for Biocryst to license Gali to a major pharmaceutical and take a royalty. I don't think the US government would want Biocryst to divest Gali.
  • 1
1 Like